🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Role of Femoral Vein Wall Thickness and Inflammatory Markers in Patients With Behcet Disease

Recruitingn/aAges 19 Years - 80 YearsAllSohag University
NCT06721234 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Evaluation of femoral vein wall thickness and inflammatory indices in patients with Behcet disease and assessment of their relation to the disease activity and related some clinical manifestations

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients fulfill the International Criteria for Behcet's Disease (ICBD) * Age above 18 years old * Patients cooperative and can answer questions * Patients who are able and willing to give informed consent Exclusion Criteria: * Other rheumatological and vascular diseases * Patients with abnormal hepatic or renal function tests , hyperlipidemia and impaired coagulation tests * Patients with hypertension , diabetes mellitus , malignant and active infectious diseases * Patients who are using aspirin and other platelet active drygs during the previous 6 months * patients who are not able and willing to give written consent
💊

What it tests

  • Not listed
📍

Where

1 site
Sohag university
Sohag, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy